An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model

Development of an opsonophagocytic killing assay for group a streptococcus

(2018) Scott Jones et al.   VACCINE

Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP

(2018) Amelia T. Soderholm et al.   Frontiers in Cellular and Infection Microbiology

Clinical development strategy for a candidate group A streptococcal vaccine

(2017) Florian Schödel et al.   VACCINE

Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial

(2017) Manisha Pandey et al.   Scientific Reports

Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci

(2016) Manisha Pandey et al.   JOURNAL OF IMMUNOLOGY

Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models

(2016) Tania Rivera-Hernandez et al.   mBio

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015) Theo Vos et al.   LANCET

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus

(2014) M. J. Walker et al.   CLINICAL MICROBIOLOGY REVIEWS

A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development

(2014) Martina Sanderson-Smith et al.   JOURNAL OF INFECTIOUS DISEASES

Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A Streptococcus Virulence

(2013) E. Chiarot et al.   mBio

Structure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A Streptococcus

(2013) A. Henningham et al.   mBio

Analysis of a Streptococcus pyogenes Puerperal Sepsis Cluster by Use of Whole-Genome Sequencing

(2012) N. L. Ben Zakour et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular Characterization of the 2011 Hong Kong Scarlet Fever Outbreak

(2012) H. Tse et al.   JOURNAL OF INFECTIOUS DISEASES

Conserved anchorless surface proteins as group A streptococcal vaccine candidates

(2012) Anna Henningham et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case

(2012) Giuliano Bensi et al.   MOLECULAR & CELLULAR PROTEOMICS

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

(2011) James B. Dale et al.   VACCINE

Multilaboratory Comparison ofStreptococcus pneumoniaeOpsonophagocytic Killing Assays and Their Level of Agreement for the Determination of Functional Antibody Activity in Human Reference Sera

(2010) Charles E. Rose et al.   Clinical and Vaccine Immunology

The Human Immune Response to Streptococcal Extracellular Antigens: Clinical, Diagnostic, and Potential Pathogenetic Implications

(2010) Dwight R. Johnson et al.   CLINICAL INFECTIOUS DISEASES

Comparison of rhesus and cynomolgus macaques in a Streptococcus pyogenes infection model for vaccine evaluation

(2010) Julie M. Skinner et al.   MICROBIAL PATHOGENESIS

Acute rheumatic fever and its consequences: A persistent threat to developing nations in the 21st century

(2009) Jennifer L. Lee et al.   AUTOIMMUNITY REVIEWS

Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis

(2009) Michael A. Gerber et al.   CIRCULATION

Global emm type distribution of group A streptococci: systematic review and implications for vaccine development

(2009) Andrew C Steer et al.   LANCET INFECTIOUS DISEASES